Liver Diseases Therapeutics Drugs
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Cystic Fibrosis Drugs Market Research Report 2024
1 Cystic Fibrosis Drugs Market Overview
1.1 Product Overview and Scope of Cystic Fibrosis Drugs
1.2 Cystic Fibrosis Drugs Segment by Type
1.2.1 Global Cystic Fibrosis Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Oral Cystic Fibrosis Drugs
1.2.3 Injection Cystic Fibrosis Drugs
1.3 Cystic Fibrosis Drugs Segment by Application
1.3.1 Global Cystic Fibrosis Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Cystic Fibrosis Drugs Market Size Estimates and Forecasts
1.4.1 Global Cystic Fibrosis Drugs Revenue 2017-2028
1.4.2 Global Cystic Fibrosis Drugs Sales 2017-2028
1.4.3 Cystic Fibrosis Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Cystic Fibrosis Drugs Market Competition by Manufacturers
2.1 Global Cystic Fibrosis Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Cystic Fibrosis Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Cystic Fibrosis Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Cystic Fibrosis Drugs Manufacturing Sites, Area Served, Product Type
2.5 Cystic Fibrosis Drugs Market Competitive Situation and Trends
2.5.1 Cystic Fibrosis Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cystic Fibrosis Drugs Players Market Share by Revenue
2.5.3 Global Cystic Fibrosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cystic Fibrosis Drugs Retrospective Market Scenario by Region
3.1 Global Cystic Fibrosis Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Cystic Fibrosis Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Cystic Fibrosis Drugs Market Facts & Figures by Country
3.3.1 North America Cystic Fibrosis Drugs Sales by Country
3.3.2 North America Cystic Fibrosis Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cystic Fibrosis Drugs Market Facts & Figures by Country
3.4.1 Europe Cystic Fibrosis Drugs Sales by Country
3.4.2 Europe Cystic Fibrosis Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cystic Fibrosis Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Cystic Fibrosis Drugs Sales by Region
3.5.2 Asia Pacific Cystic Fibrosis Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Cystic Fibrosis Drugs Market Facts & Figures by Country
3.6.1 Latin America Cystic Fibrosis Drugs Sales by Country
3.6.2 Latin America Cystic Fibrosis Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cystic Fibrosis Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Cystic Fibrosis Drugs Sales by Country
3.7.2 Middle East and Africa Cystic Fibrosis Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cystic Fibrosis Drugs Historic Market Analysis by Type
4.1 Global Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)
4.2 Global Cystic Fibrosis Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Cystic Fibrosis Drugs Price by Type (2017-2022)
5 Global Cystic Fibrosis Drugs Historic Market Analysis by Application
5.1 Global Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)
5.2 Global Cystic Fibrosis Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Cystic Fibrosis Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Actavis
6.1.1 Actavis Corporation Information
6.1.2 Actavis Description and Business Overview
6.1.3 Actavis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Actavis Cystic Fibrosis Drugs Product Portfolio
6.1.5 Actavis Recent Developments/Updates
6.2 F. Hoffmann-La Roche
6.2.1 F. Hoffmann-La Roche Corporation Information
6.2.2 F. Hoffmann-La Roche Description and Business Overview
6.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Portfolio
6.2.5 F. Hoffmann-La Roche Recent Developments/Updates
6.3 Gilead Sciences
6.3.1 Gilead Sciences Corporation Information
6.3.2 Gilead Sciences Description and Business Overview
6.3.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Gilead Sciences Cystic Fibrosis Drugs Product Portfolio
6.3.5 Gilead Sciences Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novartis Cystic Fibrosis Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Vertex Pharmaceuticals
6.5.1 Vertex Pharmaceuticals Corporation Information
6.5.2 Vertex Pharmaceuticals Description and Business Overview
6.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
6.5.5 Vertex Pharmaceuticals Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Abbott Cystic Fibrosis Drugs Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 Anthera Pharmaceuticals
6.6.1 Anthera Pharmaceuticals Corporation Information
6.6.2 Anthera Pharmaceuticals Description and Business Overview
6.6.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
6.7.5 Anthera Pharmaceuticals Recent Developments/Updates
6.8 Arcturus Therapeutics
6.8.1 Arcturus Therapeutics Corporation Information
6.8.2 Arcturus Therapeutics Description and Business Overview
6.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Arcturus Therapeutics Cystic Fibrosis Drugs Product Portfolio
6.8.5 Arcturus Therapeutics Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Boehringer Ingelheim Cystic Fibrosis Drugs Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Chiesi Farmaceutici
6.10.1 Chiesi Farmaceutici Corporation Information
6.10.2 Chiesi Farmaceutici Description and Business Overview
6.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Chiesi Farmaceutici Cystic Fibrosis Drugs Product Portfolio
6.10.5 Chiesi Farmaceutici Recent Developments/Updates
6.11 Corbus Pharmaceuticals
6.11.1 Corbus Pharmaceuticals Corporation Information
6.11.2 Corbus Pharmaceuticals Cystic Fibrosis Drugs Description and Business Overview
6.11.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
6.11.5 Corbus Pharmaceuticals Recent Developments/Updates
6.12 Genzyme
6.12.1 Genzyme Corporation Information
6.12.2 Genzyme Cystic Fibrosis Drugs Description and Business Overview
6.12.3 Genzyme Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Genzyme Cystic Fibrosis Drugs Product Portfolio
6.12.5 Genzyme Recent Developments/Updates
6.13 Insmed
6.13.1 Insmed Corporation Information
6.13.2 Insmed Cystic Fibrosis Drugs Description and Business Overview
6.13.3 Insmed Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Insmed Cystic Fibrosis Drugs Product Portfolio
6.13.5 Insmed Recent Developments/Updates
6.14 Johnson & Johnson
6.14.1 Johnson & Johnson Corporation Information
6.14.2 Johnson & Johnson Cystic Fibrosis Drugs Description and Business Overview
6.14.3 Johnson & Johnson Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Johnson & Johnson Cystic Fibrosis Drugs Product Portfolio
6.14.5 Johnson & Johnson Recent Developments/Updates
6.15 Merck Sharp & Dohme
6.15.1 Merck Sharp & Dohme Corporation Information
6.15.2 Merck Sharp & Dohme Cystic Fibrosis Drugs Description and Business Overview
6.15.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Merck Sharp & Dohme Cystic Fibrosis Drugs Product Portfolio
6.15.5 Merck Sharp & Dohme Recent Developments/Updates
6.16 Neovii Biotech
6.16.1 Neovii Biotech Corporation Information
6.16.2 Neovii Biotech Cystic Fibrosis Drugs Description and Business Overview
6.16.3 Neovii Biotech Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Neovii Biotech Cystic Fibrosis Drugs Product Portfolio
6.16.5 Neovii Biotech Recent Developments/Updates
6.17 Novo Nordisk
6.17.1 Novo Nordisk Corporation Information
6.17.2 Novo Nordisk Cystic Fibrosis Drugs Description and Business Overview
6.17.3 Novo Nordisk Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Novo Nordisk Cystic Fibrosis Drugs Product Portfolio
6.17.5 Novo Nordisk Recent Developments/Updates
6.18 PharmaSwiss
6.18.1 PharmaSwiss Corporation Information
6.18.2 PharmaSwiss Cystic Fibrosis Drugs Description and Business Overview
6.18.3 PharmaSwiss Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.18.4 PharmaSwiss Cystic Fibrosis Drugs Product Portfolio
6.18.5 PharmaSwiss Recent Developments/Updates
6.19 Pharmaxis
6.19.1 Pharmaxis Corporation Information
6.19.2 Pharmaxis Cystic Fibrosis Drugs Description and Business Overview
6.19.3 Pharmaxis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Pharmaxis Cystic Fibrosis Drugs Product Portfolio
6.19.5 Pharmaxis Recent Developments/Updates
6.20 Proteostasis Therapeutics
6.20.1 Proteostasis Therapeutics Corporation Information
6.20.2 Proteostasis Therapeutics Cystic Fibrosis Drugs Description and Business Overview
6.20.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Proteostasis Therapeutics Cystic Fibrosis Drugs Product Portfolio
6.20.5 Proteostasis Therapeutics Recent Developments/Updates
6.21 PTC Therapeutics
6.21.1 PTC Therapeutics Corporation Information
6.21.2 PTC Therapeutics Cystic Fibrosis Drugs Description and Business Overview
6.21.3 PTC Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.21.4 PTC Therapeutics Cystic Fibrosis Drugs Product Portfolio
6.21.5 PTC Therapeutics Recent Developments/Updates
6.22 United Medical
6.22.1 United Medical Corporation Information
6.22.2 United Medical Cystic Fibrosis Drugs Description and Business Overview
6.22.3 United Medical Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.22.4 United Medical Cystic Fibrosis Drugs Product Portfolio
6.22.5 United Medical Recent Developments/Updates
6.23 Venus Remedies
6.23.1 Venus Remedies Corporation Information
6.23.2 Venus Remedies Cystic Fibrosis Drugs Description and Business Overview
6.23.3 Venus Remedies Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Venus Remedies Cystic Fibrosis Drugs Product Portfolio
6.23.5 Venus Remedies Recent Developments/Updates
7 Cystic Fibrosis Drugs Manufacturing Cost Analysis
7.1 Cystic Fibrosis Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cystic Fibrosis Drugs
7.4 Cystic Fibrosis Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cystic Fibrosis Drugs Distributors List
8.3 Cystic Fibrosis Drugs Customers
9 Cystic Fibrosis Drugs Market Dynamics
9.1 Cystic Fibrosis Drugs Industry Trends
9.2 Cystic Fibrosis Drugs Market Drivers
9.3 Cystic Fibrosis Drugs Market Challenges
9.4 Cystic Fibrosis Drugs Market Restraints
10 Global Market Forecast
10.1 Cystic Fibrosis Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cystic Fibrosis Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Cystic Fibrosis Drugs by Type (2023-2028)
10.2 Cystic Fibrosis Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cystic Fibrosis Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Cystic Fibrosis Drugs by Application (2023-2028)
10.3 Cystic Fibrosis Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cystic Fibrosis Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Cystic Fibrosis Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Cystic Fibrosis Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
Table 2. Global Cystic Fibrosis Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
Table 3. Global Cystic Fibrosis Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Cystic Fibrosis Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Cystic Fibrosis Drugs Sales (K Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Cystic Fibrosis Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Cystic Fibrosis Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Cystic Fibrosis Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Cystic Fibrosis Drugs Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Cystic Fibrosis Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Cystic Fibrosis Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cystic Fibrosis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystic Fibrosis Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Cystic Fibrosis Drugs Sales by Region (2017-2022) & (K Pcs)
Table 16. Global Cystic Fibrosis Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Cystic Fibrosis Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Cystic Fibrosis Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Cystic Fibrosis Drugs Sales by Country (2017-2022) & (K Pcs)
Table 20. North America Cystic Fibrosis Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Cystic Fibrosis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Cystic Fibrosis Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Cystic Fibrosis Drugs Sales by Country (2017-2022) & (K Pcs)
Table 24. Europe Cystic Fibrosis Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Cystic Fibrosis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Cystic Fibrosis Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Cystic Fibrosis Drugs Sales by Region (2017-2022) & (K Pcs)
Table 28. Asia Pacific Cystic Fibrosis Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Cystic Fibrosis Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Cystic Fibrosis Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Cystic Fibrosis Drugs Sales by Country (2017-2022) & (K Pcs)
Table 32. Latin America Cystic Fibrosis Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Cystic Fibrosis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Cystic Fibrosis Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Cystic Fibrosis Drugs Sales by Country (2017-2022) & (K Pcs)
Table 36. Middle East and Africa Cystic Fibrosis Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Cystic Fibrosis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Cystic Fibrosis Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)
Table 40. Global Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Cystic Fibrosis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Cystic Fibrosis Drugs Revenue Share by Type (2017-2022)
Table 43. Global Cystic Fibrosis Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 44. Global Cystic Fibrosis Drugs Sales (K Pcs) by Application (2017-2022)
Table 45. Global Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)
Table 46. Global Cystic Fibrosis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Cystic Fibrosis Drugs Revenue Share by Application (2017-2022)
Table 48. Global Cystic Fibrosis Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 49. Actavis Corporation Information
Table 50. Actavis Description and Business Overview
Table 51. Actavis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 52. Actavis Cystic Fibrosis Drugs Product
Table 53. Actavis Recent Developments/Updates
Table 54. F. Hoffmann-La Roche Corporation Information
Table 55. F. Hoffmann-La Roche Description and Business Overview
Table 56. F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 57. F. Hoffmann-La Roche Cystic Fibrosis Drugs Product
Table 58. F. Hoffmann-La Roche Recent Developments/Updates
Table 59. Gilead Sciences Corporation Information
Table 60. Gilead Sciences Description and Business Overview
Table 61. Gilead Sciences Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 62. Gilead Sciences Cystic Fibrosis Drugs Product
Table 63. Gilead Sciences Recent Developments/Updates
Table 64. Novartis Corporation Information
Table 65. Novartis Description and Business Overview
Table 66. Novartis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 67. Novartis Cystic Fibrosis Drugs Product
Table 68. Novartis Recent Developments/Updates
Table 69. Vertex Pharmaceuticals Corporation Information
Table 70. Vertex Pharmaceuticals Description and Business Overview
Table 71. Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 72. Vertex Pharmaceuticals Cystic Fibrosis Drugs Product
Table 73. Vertex Pharmaceuticals Recent Developments/Updates
Table 74. Abbott Corporation Information
Table 75. Abbott Description and Business Overview
Table 76. Abbott Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 77. Abbott Cystic Fibrosis Drugs Product
Table 78. Abbott Recent Developments/Updates
Table 79. Anthera Pharmaceuticals Corporation Information
Table 80. Anthera Pharmaceuticals Description and Business Overview
Table 81. Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 82. Anthera Pharmaceuticals Cystic Fibrosis Drugs Product
Table 83. Anthera Pharmaceuticals Recent Developments/Updates
Table 84. Arcturus Therapeutics Corporation Information
Table 85. Arcturus Therapeutics Description and Business Overview
Table 86. Arcturus Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 87. Arcturus Therapeutics Cystic Fibrosis Drugs Product
Table 88. Arcturus Therapeutics Recent Developments/Updates
Table 89. Boehringer Ingelheim Corporation Information
Table 90. Boehringer Ingelheim Description and Business Overview
Table 91. Boehringer Ingelheim Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 92. Boehringer Ingelheim Cystic Fibrosis Drugs Product
Table 93. Boehringer Ingelheim Recent Developments/Updates
Table 94. Chiesi Farmaceutici Corporation Information
Table 95. Chiesi Farmaceutici Description and Business Overview
Table 96. Chiesi Farmaceutici Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 97. Chiesi Farmaceutici Cystic Fibrosis Drugs Product
Table 98. Chiesi Farmaceutici Recent Developments/Updates
Table 99. Corbus Pharmaceuticals Corporation Information
Table 100. Corbus Pharmaceuticals Description and Business Overview
Table 101. Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 102. Corbus Pharmaceuticals Cystic Fibrosis Drugs Product
Table 103. Corbus Pharmaceuticals Recent Developments/Updates
Table 104. Genzyme Corporation Information
Table 105. Genzyme Description and Business Overview
Table 106. Genzyme Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 107. Genzyme Cystic Fibrosis Drugs Product
Table 108. Genzyme Recent Developments/Updates
Table 109. Insmed Corporation Information
Table 110. Insmed Description and Business Overview
Table 111. Insmed Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. Insmed Cystic Fibrosis Drugs Product
Table 113. Insmed Recent Developments/Updates
Table 114. Johnson & Johnson Corporation Information
Table 115. Johnson & Johnson Description and Business Overview
Table 116. Johnson & Johnson Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. Johnson & Johnson Cystic Fibrosis Drugs Product
Table 118. Johnson & Johnson Recent Developments/Updates
Table 119. Merck Sharp & Dohme Corporation Information
Table 120. Merck Sharp & Dohme Description and Business Overview
Table 121. Merck Sharp & Dohme Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 122. Merck Sharp & Dohme Cystic Fibrosis Drugs Product
Table 123. Merck Sharp & Dohme Recent Developments/Updates
Table 124. Neovii Biotech Corporation Information
Table 125. Neovii Biotech Description and Business Overview
Table 126. Neovii Biotech Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 127. Neovii Biotech Cystic Fibrosis Drugs Product
Table 128. Neovii Biotech Recent Developments/Updates
Table 129. Novo Nordisk Corporation Information
Table 130. Novo Nordisk Description and Business Overview
Table 131. Novo Nordisk Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 132. Novo Nordisk Cystic Fibrosis Drugs Product
Table 133. Novo Nordisk Recent Developments/Updates
Table 134. PharmaSwiss Corporation Information
Table 135. PharmaSwiss Description and Business Overview
Table 136. PharmaSwiss Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 137. PharmaSwiss Cystic Fibrosis Drugs Product
Table 138. PharmaSwiss Recent Developments/Updates
Table 139. Pharmaxis Corporation Information
Table 140. Pharmaxis Description and Business Overview
Table 141. Pharmaxis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 142. Pharmaxis Cystic Fibrosis Drugs Product
Table 143. Pharmaxis Recent Developments/Updates
Table 144. Proteostasis Therapeutics Corporation Information
Table 145. Proteostasis Therapeutics Description and Business Overview
Table 146. Proteostasis Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 147. Proteostasis Therapeutics Cystic Fibrosis Drugs Product
Table 148. Proteostasis Therapeutics Recent Developments/Updates
Table 149. PTC Therapeutics Corporation Information
Table 150. PTC Therapeutics Description and Business Overview
Table 151. PTC Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 152. PTC Therapeutics Cystic Fibrosis Drugs Product
Table 153. PTC Therapeutics Recent Developments/Updates
Table 154. United Medical Corporation Information
Table 155. United Medical Description and Business Overview
Table 156. United Medical Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 157. United Medical Cystic Fibrosis Drugs Product
Table 158. United Medical Recent Developments/Updates
Table 159. Venus Remedies Corporation Information
Table 160. Venus Remedies Description and Business Overview
Table 161. Venus Remedies Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 162. Venus Remedies Cystic Fibrosis Drugs Product
Table 163. Venus Remedies Recent Developments/Updates
Table 164. Production Base and Market Concentration Rate of Raw Material
Table 165. Key Suppliers of Raw Materials
Table 166. Cystic Fibrosis Drugs Distributors List
Table 167. Cystic Fibrosis Drugs Customers List
Table 168. Cystic Fibrosis Drugs Market Trends
Table 169. Cystic Fibrosis Drugs Market Drivers
Table 170. Cystic Fibrosis Drugs Market Challenges
Table 171. Cystic Fibrosis Drugs Market Restraints
Table 172. Global Cystic Fibrosis Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
Table 173. Global Cystic Fibrosis Drugs Sales Market Share Forecast by Type (2023-2028)
Table 174. Global Cystic Fibrosis Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 175. Global Cystic Fibrosis Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 176. Global Cystic Fibrosis Drugs Sales Forecast by Application (2023-2028) & (K Pcs)
Table 177. Global Cystic Fibrosis Drugs Sales Market Share Forecast by Application (2023-2028)
Table 178. Global Cystic Fibrosis Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 179. Global Cystic Fibrosis Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 180. Global Cystic Fibrosis Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 181. Global Cystic Fibrosis Drugs Sales Market Share Forecast by Region (2023-2028)
Table 182. Global Cystic Fibrosis Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 183. Global Cystic Fibrosis Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cystic Fibrosis Drugs
Figure 2. Global Cystic Fibrosis Drugs Market Share by Type in 2021 & 2028
Figure 3. Oral Cystic Fibrosis Drugs Product Picture
Figure 4. Injection Cystic Fibrosis Drugs Product Picture
Figure 5. Global Cystic Fibrosis Drugs Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Other
Figure 9. Global Cystic Fibrosis Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Cystic Fibrosis Drugs Market Size (2017-2028) & (US$ Million)
Figure 11. Global Cystic Fibrosis Drugs Sales (2017-2028) & (K Pcs)
Figure 12. Cystic Fibrosis Drugs Sales Share by Manufacturers in 2021
Figure 13. Global Cystic Fibrosis Drugs Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Cystic Fibrosis Drugs Players: Market Share by Revenue in 2021
Figure 15. Cystic Fibrosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Cystic Fibrosis Drugs Sales Market Share by Region (2017-2022)
Figure 17. Global Cystic Fibrosis Drugs Sales Market Share by Region in 2021
Figure 18. Global Cystic Fibrosis Drugs Revenue Market Share by Region (2017-2022)
Figure 19. Global Cystic Fibrosis Drugs Revenue Market Share by Region in 2021
Figure 20. U.S. Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Cystic Fibrosis Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Cystic Fibrosis Drugs by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Cystic Fibrosis Drugs
Figure 44. Manufacturing Process Analysis of Cystic Fibrosis Drugs
Figure 45. Cystic Fibrosis Drugs Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Actavis F. Hoffmann-La Roche Gilead Sciences Novartis Vertex Pharmaceuticals Abbott Anthera Pharmaceuticals Arcturus Therapeutics Boehringer Ingelheim Chiesi Farmaceutici Corbus Pharmaceuticals Genzyme Insmed Johnson & Johnson Merck Sharp & Dohme Neovii Biotech Novo Nordisk PharmaSwiss Pharmaxis Proteostasis Therapeutics PTC Therapeutics United Medical Venus Remedies